EGFR and non-small cell lung carcinoma: Moreover, CsA promotes gefitinib-induced apoptosis by inhibiting the signal transducer and activator of the transcription 3 (STAT3) pathway in EGFR-TKI-sensitive and -resistant NSCLC cells [19].